RCEL logo

RCEL Avita Medical Inc.

NASDAQ · Medical - Devices · Healthcare

$7.85
-0.16 (-2.00%)

AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company’s lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds and full-thickness skin defects, as well as for repigmentation of stable depigmented vitilig…

Market Cap: $195.02Mavitamedical.com

Price (90d)

No price history yet — the daily price refresh runs once a day.

Signal Score (90d)

120
100107113120
Aug 9Aug 12

Quote

Day Range
$7.66 – $8.17
52-Week Range
$3.22 – $8.55
Volume
$263.2K
Market Cap
$195.02M
50-Day Avg
$4.83
200-Day Avg
$4.28
Prev Close
$8.01
Open
$8.01

Valuation & Ratios

P/E Ratio
-1.98
EPS
$-1.74
P/B Ratio
-5.77
P/S Ratio
1.34
Debt/Equity
-2.77
Current Ratio
0.57
Dividend Yield
+0.0%
Gross Margin
+82.1%

Returns & Efficiency

Return on Equity
+291.8%
Return on Assets
-86.2%
FCF Yield
-34.3%
EV/EBITDA
-3.20

Revenue & Net Income (Annual)

Fiscal YearRevenueNet IncomeEPS
2025$71.61M$-48.59M$-1.74
2024$64.25M$-61.84M$-2.39
2023$50.14M$-35.38M$-1.40
2022$34.42M$-26.66M$-1.07
2021$33.02M$-25.14M$-1.03

Social Signal Score

63
5d
70
1 mentions
30d
61
2 mentions
60d
61
2 mentions
90d
61
2 mentions
news: 2

Earnings

Thu, Nov 5(in 3 months)

Consensus estimate $-0.27 per share

2of 7 quarters beat consensus

Typical surprise -7.0% (median, so one quarter with a near-zero estimate can't distort it)

  • Thu, Aug 6$-0.25 vs $-0.29beat
  • Thu, May 14$-0.35 vs $-0.35beat
  • Thu, Feb 12$-0.38 vs $-0.36miss
  • Thu, Nov 6$-0.46 vs $-0.43miss
  • Thu, Aug 7$-0.38 vs $-0.26miss
  • Thu, May 8$-0.53 vs $-0.39miss

Estimates and results for RCEL via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.

Valuation

RCELhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.

Mentions (2)

  • Newsseekingalpha.com·2d ago·Positive

    AVITA Medical, Inc. (RCEL) Shareholder/Analyst Call Transcript AVITA Medical, Inc. (RCEL) Shareholder/Analyst Call Transcript

    View source ↗
  • Newsglobenewswire.com·5d ago·Neutral

    AVITA Medical to Host Investor Webinar Briefing VALENCIA, Calif., Aug. 09, 2026 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, invites shareholders and prospective investors to attend its investor webinar briefing and presentation by Cary Vance, President and Chief Executive Officer, and David O'Toole, Chief Financial Officer, on August 12, 2026, at 4:00 p.m.

    View source ↗